These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Polyepitope protein incorporated the HIV-1 mimotope recognized by monoclonal antibody 2G12. Karpenko LI, Scherbakova NS, Chikaev AN, Tumanova OY, Lebedev LR, Shalamova LA, Pyankova OG, Ryzhikov AB, Ilyichev AA. Mol Immunol; 2012 Apr; 50(4):193-9. PubMed ID: 22341130 [Abstract] [Full Text] [Related]
5. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses. Borrego B, Fernandez-Pacheco P, Ganges L, Domenech N, Fernandez-Borges N, Sobrino F, Rodríguez F. Vaccine; 2006 May 01; 24(18):3889-99. PubMed ID: 16563575 [Abstract] [Full Text] [Related]
6. Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine. Wingard JB, Anderson B, Weissman D. Eur J Immunol; 2008 May 01; 38(5):1310-20. PubMed ID: 18412164 [Abstract] [Full Text] [Related]
12. Clustered epitopes within the Gag-Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens. Bolesta E, Gzyl J, Wierzbicki A, Kmieciak D, Kowalczyk A, Kaneko Y, Srinivasan A, Kozbor D. Virology; 2005 Feb 20; 332(2):467-79. PubMed ID: 15680412 [Abstract] [Full Text] [Related]
13. Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines. Michel M, Lone YC, Centlivre M, Roux P, Wain-Hobson S, Sala M. Vaccine; 2007 Feb 26; 25(10):1901-11. PubMed ID: 17005303 [Abstract] [Full Text] [Related]